Editor’s note: This is an automatically generated transcript. Please notify editor@healio.com if there are concerns regarding accuracy of the transcription. We're excited in the multiple myeloma that ...
PAX5 regulates B-cell identity by controlling the activation of its genetic program, guiding B-cell progenitors through the maturation process. According to the research, this is an exceptionally ...
Sequential Infusion of Mesenchymal Stem Cell for Graft-Versus-Host Disease Prevention in Haploidentical Hematopoietic Stem Cell Transplantation: An Open-Label, Multicenter, Randomized Controlled ...
Over four hundred people, 80% of them being children under 14 years old, will be diagnosed with B-cell Acute Lymphoblastic Leukaemia (B-ALL) next year in Spain, according to the latest projections ...
CDR111, an experimental MS therapy designed to eliminate harmful B-cells, reached an early development milestone.
In this interview, industry experts Mathieu Bennet and Dustin Whitson explore how automation and single-cell technologies are transforming high-throughput B-cell cloning for antibody discovery. Can ...
Pharmaceutical Technology on MSN
Kali and Sanofi sign licence agreement for KT501 autoimmune disease antibody
Under the agreement, Kali Therapeutics is set to receive $180m in upfront and near-term payments.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results